Literature DB >> 3953891

Possible mechanisms for lactate's induction of panic.

M R Liebowitz, J M Gorman, A Fyer, D Dillon, M Levitt, D F Klein.   

Abstract

Forty-three patients with panic disorder or agoraphobia with panic attacks and 20 control subjects received 0.5 M racemic sodium lactate intravenous infusions, single-blind as to duration and sequence. During the procedure, pulse; blood pressure; blood L-lactate and pyruvate; plasma ionized calcium, phosphate, prolactin, epinephrine, norepinephrine, and cortisol levels; and venous PCO2, pH, and bicarbonate were measured in an attempt to clarify the mechanism of lactate-induced panic attacks. During the infusion, 72% of the patients but none of the control subjects had panic attacks. The laboratory findings suggest that peripheral catecholamine surge is not the mechanism by which lactate causes panic, although elevated epinephrine may be a predisposing factor. Heightened central noradrenergic activity was present in many but not all of the attacks. Contrary to previous hypotheses, neither depression of ionized calcium nor induction of metabolic alkalosis appears sufficient to cause panic during lactate infusion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3953891     DOI: 10.1176/ajp.143.4.495

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  14 in total

1.  Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.

Authors:  M Iijima; T Yoshimizu; T Shimazaki; K Tokugawa; K Fukumoto; S Kurosu; T Kuwada; Y Sekiguchi; S Chaki
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

2.  Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder.

Authors:  R S Kahn; G M Asnis; S Wetzler; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 3.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 4.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

5.  Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.

Authors:  J A Den Boer; H G Westenberg
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 6.  Lactate shuttling and lactate use as fuel after traumatic brain injury: metabolic considerations.

Authors:  Gerald A Dienel
Journal:  J Cereb Blood Flow Metab       Date:  2014-09-10       Impact factor: 6.200

7.  Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior.

Authors:  Tj Sajdyk; Pl Johnson; Sd Fitz; A Shekhar
Journal:  J Psychopharmacol       Date:  2008-02-28       Impact factor: 4.153

8.  Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic.

Authors:  Pl Johnson; Ca Lowry; W Truitt; A Shekhar
Journal:  J Psychopharmacol       Date:  2008-02-28       Impact factor: 4.153

Review 9.  Theoretical and therapeutic considerations for the anxiety disorders.

Authors:  L Taylor; J Gorman
Journal:  Psychiatr Q       Date:  1992

10.  A key role for orexin in panic anxiety.

Authors:  Philip L Johnson; William Truitt; Stephanie D Fitz; Pamela E Minick; Amy Dietrich; Sonal Sanghani; Lil Träskman-Bendz; Andrew W Goddard; Lena Brundin; Anantha Shekhar
Journal:  Nat Med       Date:  2009-12-27       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.